Eribulin in Brain Metastases From HER2-negative Breast Cancer
Condition: Metastatic Breast Cancer Intervention: Drug: Eribulin Sponsors: Institut Paoli-Calmettes; Eisai Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Neurology | Research